KLRK1 and neoplasm: NK cells expanded in vitro recognize tumor antigen UL16-binding protein 2/5/6 on anaplastic thyroid carcinoma cells via natural killer group 2, member D receptor (NKG2D), thereby directing NK-mediated tumor lysis [47].